MAAT INDEX

CLAIM #2353 · AbbVie Inc (ABBV) · 2024Q1 earnings call · Apr 26, 2024 · due Dec 31, 2026

We've highlighted that it may start to emerge in '25 and probably be much more visible by '26.

Jeff Stewart · EVP, Chief Commercial Officer

PENDING
graded after results covering Dec 31, 2026 are reported

How to check this claim

Look at: Emergence/visibility of the referenced trend or metric (e.g., revenue impact or growth contribution as disclosed by management), as described in company commentary

It came true if: Management or reported financials indicate visible impact by FY2026 (qualitative confirmation in earnings calls/10-K commentary, or a measurable inflection in the related reported figure by FY2026 vs FY2025)

Where: Company earnings calls and 10-K/10-Q management discussion for FY2025 and FY2026

Verify independently

SEC filings for ABBV · Claim quote is verbatim from the 2024Q1 earnings call.